Host, viral, and vaccine factors that determine protective efficacy induced by rotavirus and virus-like particles (VLPs)

被引:34
作者
Blutt, SE
Warfield, KL
O'Neal, CM
Estes, MK
Conner, ME
机构
[1] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA
[2] Michael E Debakey Vet Affairs Med Ctr, Houston, TX 77030 USA
关键词
virus-like particles; rotavirus; protective immunity;
D O I
10.1016/j.vaccine.2005.08.090
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Critical factors that are important in protection from rotavirus infection have remained elusive. We demonstrate here that inbred mice (C57BL/6 and BALB/c) exhibit differences in: (1) susceptibility to and (2) VLP-induced protection from rotavirus infection. Comparing protection induced by 2/4/6/7-VLPs with inactivated and live rotavirus, intranasally induced protection was dependent on dsRNA or minor structural proteins and correlated with intestinal antibody, while orally induced protection required immunization with replicating virus. Combination oral/intranasal vaccination did not improve VLP protective efficacy. These studies indicate that host, viral, and vaccine factors determine the level of protective efficacy induced by VLPs. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1170 / 1179
页数:10
相关论文
共 48 条
  • [41] Heterologous protection induced by the inner capsid proteins of rotavirus requires transcytosis of mucosal immunoglobulins
    Schwartz-Cornil, I
    Benureau, Y
    Greenberg, H
    Hendrickson, BA
    Cohen, J
    [J]. JOURNAL OF VIROLOGY, 2002, 76 (16) : 8110 - 8117
  • [42] Epidemiology, etiology, and impact of traveler's diarrhea in Jamaica
    Steffen, R
    Collard, F
    Tornieporth, N
    Campbell-Forrester, S
    Ashley, D
    Thompson, S
    Mathewson, JJ
    Maes, E
    Stephenson, B
    DuPont, HL
    von Sonnenburg, F
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (09): : 811 - 817
  • [43] ANTIGENIC COMPARISONS OF 2 NEW ROTAVIRUSES FROM RHESUS-MONKEYS
    STUKER, G
    OSHIRO, LS
    SCHMIDT, NJ
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1980, 11 (02) : 202 - 203
  • [44] DEVELOPMENT OF AN ADULT-MOUSE MODEL FOR STUDIES ON PROTECTION AGAINST ROTAVIRUS
    WARD, RL
    MCNEAL, MM
    SHERIDAN, JF
    [J]. JOURNAL OF VIROLOGY, 1990, 64 (10) : 5070 - 5075
  • [45] WARD RL, 1996, J INFECT DIS S1, V174, P51
  • [46] Immune responses and protection obtained with rotavirus VP6 DNA vaccines given by intramuscular injection
    Yang, KJ
    Wang, SX
    Chang, KO
    Lu, S
    Saif, LJ
    Greenberg, HB
    Brinker, JP
    Herrmann, JE
    [J]. VACCINE, 2001, 19 (23-24) : 3285 - 3291
  • [47] Correlation of tissue distribution, developmental phenotype, and intestinal homing receptor expression of antigen-specific B cells during the murine anti-rotavirus immune response
    Youngman, KR
    Franco, MA
    Kuklin, NA
    Rott, LS
    Butcher, EC
    Greenberg, HB
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 168 (05) : 2173 - 2181
  • [48] Intranasal administration of 2/6-rotavirus-like particles with mutant Escherichia coli heat-labile toxin (LT-R192G) induces antibody-secreting cell responses but not protective immunity in gnotobiotic pigs
    Yuan, LJ
    Geyer, A
    Hodgins, DC
    Fan, ZQ
    Qian, Y
    Chang, KO
    Crawford, SE
    Parreño, V
    Ward, LA
    Estes, MK
    Conner, ME
    Saif, LJ
    [J]. JOURNAL OF VIROLOGY, 2000, 74 (19) : 8843 - 8853